No Data
No Data
Is China Reform Health Management and Services Group (SZSE:000503) Using Debt In A Risky Way?
Guoxin Health: Report for the third quarter of 2024
China Reform Health Management and Services Group (000503.SZ) released its performance for the first three quarters, with a net loss of 30.9467 million yuan.
China Reform Health Management and Services Group (000503.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...
China Reform Health Management and Services Group (000503.SZ): a net loss of 30.9467 million yuan in the first three quarters.
Grain surges on October 25th, china reform health management and services group (000503.SZ) announced its third quarter report. In the first three quarters of 2024, the company achieved a revenue of 0.2 billion yuan, a year-on-year increase of 24.40%; the net loss attributable to shareholders of the listed company was 30.9467 million yuan, a year-on-year increase of 71.49%; the net loss after deducting non-recurring gains and losses was 0.109 billion yuan, a year-on-year increase of 7.69%; and the basic earnings per share was -0.0316 yuan per share.
China Reform Health Management and Services Group (000503.SZ): Provides third-party services for precise payment of medical insurance for medical security departments in Shenyang.
China Reform Health Management and Services Group (000503.SZ) stated on the investor interaction platform that the company provides third-party services for precise payment of medical insurance and intelligent monitoring of big data for the medical security department in Shenyang.
Guoxin Health: 2024 Semi-Annual Report
No Data
No Data